Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Patient group:
- People who have been diagnosed with stage I, II, or III breast cancer
- People who finished their chemotherapy treatment (given before or after surgery) less than three weeks ago
Control group (comparison group):
- Women who have never had cancer and who are of a similar age, weight, and activity level to the patient group
Who may not be able to join:
- People who have a history of any cancer
- People who have any known long-term or ongoing health condition
- Minors or adults who are under legal protection (confirm with trial site)
- People who have psychiatric, muscle and bone, or nervous system problems
- People who have a pacemaker implanted
- People who are pregnant
- People who have any reason why a temporary, controlled restriction of blood flow to a limb would not be safe for them (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Characterize the metaboreflex in breast cancer patients at the end of chemotherapy treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.